Business Daily cover image

Business Weekly

Business Daily

00:00

Living With Alsheimers

A new drug to treat alsimes disease was approved in the us this june. The biagen drug called adal helm was approved without definitive evidence that patients will benefit. This has led lawmakers to launch an investigation into the drugs pricing and the approval process.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app